|
1
|
Smalley WE and DuBois RN: Colorectal
cancer and non-steroidal anti-inflammatory drugs. Adv Pharmacol.
39:1–20. 1997. View Article : Google Scholar
|
|
2
|
Tsujii M, Kawano S, Tsuji S, Sawaoka H,
Hori M and DuBois RN: Cyclooxygenase regulates angiogenesis induced
by colon cancer cells. Cell. 93:705–716. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Yao M, Kargman S, Lam EC, et al:
Inhibition of cyclooxygenase-2 by rofecoxib attenuates the growth
and metastatic potential of colorectal carcinoma in mice. Cancer
Res. 63:586–592. 2003.PubMed/NCBI
|
|
4
|
Steinbach G, Lynch PM, Phillips RK, et al:
The effect of celecoxib, a cyclooxygenase-2 inhibitor, in familial
adenomatous polyposis. N Engl J Med. 342:1946–1952. 2000.
View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Tomozawa S, Nagawa H, Tsuno N, et al:
Inhibition of haematogenous metastasis of colon cancer in mice by a
selective COX-2 inhibitor, JTE-522. Br J Cancer. 81:1274–1279.
1999. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Vane JR: Inhibition of prostaglandin
synthesis as a mechanism of action for aspirin-like drugs. Nat New
Biol. 231:232–235. 1971. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Wolfe MM, Lichtenstein DR and Singh G:
Gastrointestinal toxicity of non-steroidal antiinflammatory drugs.
N Engl J Med. 340:1888–1899. 1999. View Article : Google Scholar
|
|
8
|
Masferrer JL, Seibert K, Zweifel B and
Needleman P: Endogenous glucocorticoids regulate an inducible
cyclooxygenase enzyme. Proc Natl Acad Sci USA. 89:3917–3921. 1992.
View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Kujubu DA, Fletcher BS, Varnum BC, Lim RW
and Herschman HR: TIS10, a phorbol ester tumor promoter-inducible
mRNA from Swiss 3T3 cells, encodes a novel prostaglandin
synthase/cyclooxygenase homologue. J Biol Chem. 266:12866–12872.
1991.
|
|
10
|
Kargman SL, O’Neill GP, Vickers PJ, Evans
JF, Mancini JA and Jothy S: Expression of prostaglandin G/H
synthase-1 and -2 protein in human colon cancer. Cancer Res.
55:2556–2559. 1995.PubMed/NCBI
|
|
11
|
Oshima M, Dinchuk JE, Kargman SL, et al:
Suppression of intestinal polyposis in ApcΔ716
knockout mice by inhibition of cyclooxygenase 2 (COX-2). Cell.
87:803–809. 1996.
|
|
12
|
Tsujii M, Kawano S and DuBois RN:
Cyclooxygenase-2 expression in human colon cancer cells increases
metastatic potential. Proc Natl Acad Sci USA. 94:3336–3340. 1997.
View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Masferrer JL, Leahy KM, Koki AT, et al:
Antiangiogenic and antitumor activities of cyclooxygenase-2
inhibitors. Cancer Res. 60:1306–1311. 2000.PubMed/NCBI
|
|
14
|
Penning TD, Talley JJ, Bertenshaw SR, et
al: Synthesis and biological evaluation of the 1,5-diarylpyrazole
class of cyclooxygenase-2 inhibitors: identification of
4-[5-(4-methyl-phenyl)-3-(trifluoromethyl)-1H-pyrazol-1-yl]benze
nesulfonamide (SC-58635, celecoxib). J Med Chem. 40:1347–1365.
1997.PubMed/NCBI
|
|
15
|
Silverstein FE, Faich G, Goldstein JL, et
al: Gastrointestinal toxicity with celecoxib vs. non-steroidal
anti-inflammatory drugs for osteoarthritis and rheumatoid
arthritis: the CLASS study: a randomized controlled trial.
Celecoxib long-term arthritis safety study. JAMA. 284:1247–1255.
2000. View Article : Google Scholar
|
|
16
|
Chen WS, Wei SJ, Liu JM, Hsiao M, Kou-Lin
J and Yang WK: Tumor invasiveness and liver metastasis of colon
cancer cells correlated with cyclooxygenase-2 (COX-2) expression
and inhibited by a COX-2-selective inhibitor, etodolac. Int J
Cancer. 91:894–899. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Kakiuchi Y, Tsuji S, Tsujii M, et al:
Cyclooxygenase-2 activity altered the cell-surface carbohydrate
antigens on colon cancer cells and enhanced liver metastasis.
Cancer Res. 62:1567–1572. 2002.PubMed/NCBI
|
|
18
|
Ninomiya I, Terada I, Yoshizumi T, et al:
Anti-metastatic effect of capecitabine on human colon cancer
xenografts in nude mouse rectum. Int J Cancer. 112:135–142. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Blin N and Stafford DW: A general method
for isolation of high molecular weight DNA from eukaryotes. Nucleic
Acids Res. 3:2303–2308. 1976. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Nagatsuka I, Yamada N, Shimizu S, et al:
Inhibitory effect of a selective cyclooxygenase-2 inhibitor on
liver metastasis of colon cancer. Int J Cancer. 100:515–519. 2002.
View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Yoshinaka R, Shibata MA, Morimoto J,
Tanigawa N and Otsuki Y: COX-2 inhibitor celecoxib suppresses tumor
growth and lung metastasis of a murine mammary cancer. Anticancer
Res. 26:4245–4254. 2006.PubMed/NCBI
|
|
22
|
Evans DM and Sloan Stakleff KD: Control of
pulmonary metastases of rat mammary cancer by inhibition of uPA and
COX-2, singly and in combination. Clin Exp Metastasis. 21:339–346.
2004. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Zhang S, Lawson KA, Simmons-Menchaca M,
Sun L, Sanders BG and Kline K: Vitamin E analog α-TEA and celecoxib
alone and together reduce human MDA-MB-435-FL-GFP breast cancer
burden and metastasis in nude mice. Breast Cancer Res Treat.
87:111–121. 2004.
|
|
24
|
Endo Y, Sasaki T, Harada F and Noguchi M:
Specific detection of metastasized human tumor cells in embryonic
chicks by the polymerase chain reaction. Jpn J Cancer Res.
81:723–726. 1990. View Article : Google Scholar
|
|
25
|
Williams CS, Tsujii M, Reese J, Dey SK and
DuBois RN: Host cyclooxygenase-2 modulates carcinoma growth. J Clin
Invest. 105:1589–1594. 2000. View
Article : Google Scholar : PubMed/NCBI
|
|
26
|
Leahy KM, Ornberg RL, Wang Y, Zweifel BS,
Koki AT and Masferrer JL: Cyclooxygenase-2 inhibition by celecoxib
reduces proliferation and induces apoptosis in angiogenic
endothelial cells in vivo. Cancer Res. 62:625–631. 2002.PubMed/NCBI
|
|
27
|
Zweifel BS, Davis TW, Ornberg RL and
Masferrer JL: Direct evidence for a role of cyclooxygenase
2-derived prostaglandin E2 in human head and neck xenograft tumors.
Cancer Res. 62:6706–6711. 2002.PubMed/NCBI
|
|
28
|
Wei D, Wang L, He Y, Xiong HQ, Abbruzzese
JL and Xie K: Celecoxib inhibits vascular endothelial growth factor
expression in and reduces angiogenesis and metastasis of human
pancreatic cancer via suppression of Sp1 transcription factor
activity. Cancer Res. 64:2030–2038. 2004. View Article : Google Scholar
|
|
29
|
Honn KV, Bockman RS and Marnett LJ:
Prostaglandins and cancer: a review of tumor initiation through
tumor metastasis. Prostaglandins. 21:833–864. 1981. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Rochels R: Pathobiochemical aspects of
corneal neovascularization. Fortschr Med. 102:101–102. 1984.(In
German).
|
|
31
|
Liu H, Yang Y, Xiao J, et al: Inhibition
of cyclooxygenase-2 suppresses lymph node metastasis via VEGF-C.
Anat Rec. 292:1577–1583. 2009. View
Article : Google Scholar : PubMed/NCBI
|
|
32
|
Backhus LM, Sievers E, Lin GY, et al:
Perioperative cyclooxygenase 2 inhibition to reduce tumor cell
adhesion and metastatic potential of circulating tumor cells in
non-small cell lung cancer. J Thorac Cardiovasc Surg. 132:297–303.
2006. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Roh JL, Sung MW, Park SW, Heo DS, Lee DW
and Kim KH: Celecoxib can prevent tumor growth and distant
metastasis in postoperative setting. Cancer Res. 64:3230–3235.
2004. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Farooqui M, Li Y, Rogers T, et al: COX-2
inhibitor celecoxib prevents chronic morphine-induced promotion of
angiogenesis, tumour growth, metastasis and mortality, without
compromising analgesia. Br J Cancer. 97:1523–1531. 2007. View Article : Google Scholar
|
